BayWa AG

BayWa AG: Changes to the Board of Management of BayWa AG

BayWa AG: Extension of the standstill agreements and increase in bridge financing

BayWa AG: Impairment tests lead to extraordinary depreciation of € 222.2 million (impairment tests in accordance with IAS 36)

BayWa AG: First draft of restructuring report is positive

BayWa AG: Standstill and bridge financing agreements concluded and further financing contributions secured

BayWa AG: Preliminary business figures for the first half of 2024, suspension of forecast and postponement of the publication of half-year figures